Autor: |
Schechet, Sid A., Garff, Kevin, Klima, Karen, Campbell, Wayne, Schocket, Lisa S. |
Zdroj: |
Retinal Cases & Brief Reports; Oct2018, Vol. 12 Issue 4, p307-309, 3p |
Abstrakt: |
Purpose: To report a case of acute retinal necrosis in a patient on anti-tumor necrosis factor a immunosuppressive therapy. Methods: Case report. Results: A 47-year-old man with psoriasis presented with blurred vision and floaters in the left eye 4 days after receiving his fourth dose of adalimumab, a tumor necrosis factor a antagonist. He was diagnosed with acute retinal necrosis and was treated with intravenous acyclovir as well as prophylactic laser barricade. Seven years later, he is 20/20 with no history of a retinal detachment. Conclusion: Physicians prescribing tumor necrosis factor a antagonist immunosuppressive therapy should be aware of the potential of developing acute retinal necrosis. [ABSTRACT FROM AUTHOR] |
Databáze: |
Supplemental Index |
Externí odkaz: |
|